April 2015 Issue of Renal And Urology News
Nephrology Cover Articles
A difference of 10 mm Hg or more in systolic blood pressure was associated with an 80% increased risk.
Researchers found 88% higher odds of negative pregnancy outcomes for women with stage 1 CKD and no classic risk factors.
Meta-analysis finds a reduction in the risk of incident and recurrent kidney stones.
Urology Cover Articles
Men who take phosphodiesterase type 5 inhibitors after radical prostatectomy are more likely to experience biochemical recurrence of disease.
No higher risk of adverse pathology among men on active surveillance who delayed surgery until signs of disease progression.
In a phase 2 trial, 72% of patients with high-grade clinical nonmuscle-invasive bladder cancer had a complete response at 3 months.
Chronic diseases such as end-stage renal disease (ESRD) have now surpassed opportunistic infections as the leading cause of death among HIV-infected patients.
News in Brief
Meta-analysis shows that use of medication is associated with an 18% lower risk.
Lixelle Beta 2-microglobulin Apheresis Column authorized for use in DRA
In a study, not a single case of metastatic disease developed among 449 men who had a tumor grade of Gleason 6 or less at ...
The medication may represent a new treatment option for dialysis patients, researchers concluded.
Baseline serum uric acid levels significantly predicted the change in estimated glomerular filtration rate (eGFR).
Practices may need to adjust schedules, time off, and compensation as the number of female urologists and nephrologists grows.
In a small randomized trial, functional and oncologic results did not differ significantly between the 2 approaches
Patients reported significantly less pain with pelvic plexus block than conventional periprostatic block.
Higher magnesium levels in hemodialysis patients with high phosphorus levels were associated with decreased cardiovascular mortality.
Researchers find no increased risk of adverse pathologic outcomes among men who put off radical prostatectomy for up to 12 months.
Patients who received the drug as part of their treatment survived longer than those on placebo by a median 4.4 months.
People least adherent to a DASH-style diet had a 3-fold increased odds of chronic kidney disease compared with those who were most adherent.
The 5-year risk of overall mortality is decreased by 50% compared with androgen deprivation therapy alone.
Overweight or obese patients treated with targeted therapy for metastatic clear-cell renal cell carcinoma found to live longer.
Over a 5-year period, cancer developed in 9.5% of hemodialysis patients, a rate much higher than would be expected in the general population.
Emergency department visit and hospitalization rates increased in wake of storm.
Median time to death was shortest in men with metastatic disease at diagnosis.
Stroke risk increases linearly with decreasing GFR rate and increasing albuminuria, according to a review and meta-analysis.
Lapascopic and percutaneous cryoablation for small renal masses are associated with similar survival, researchers say.
Renal and Urology News Articles
- Aggressive Therapy Warranted for Gleason 10 Prostate Cancer
- PET/CT May Improve Imaging of Recurrent Prostate Cancer
- Adding MRI Does Not Boost Prostate Cancer Upgrading Rate
- Both High and Low Uric Acid Levels Tied to Higher Mortality
- Trulicity Labeling Updated to Include Data on T2D Patients With CKD
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)